Lesur, O.; Segal, E.D.; Rego, K.; Mercat, A.; Asfar, P.; Chagnon, F.
Process-Specific Blood Biomarkers and Outcomes in COVID-19 Versus Non-COVID-19 ARDS (APEL–COVID Study): A Prospective, Observational Cohort Study. J. Clin. Med. 2024, 13, 5919.
https://doi.org/10.3390/jcm13195919
AMA Style
Lesur O, Segal ED, Rego K, Mercat A, Asfar P, Chagnon F.
Process-Specific Blood Biomarkers and Outcomes in COVID-19 Versus Non-COVID-19 ARDS (APEL–COVID Study): A Prospective, Observational Cohort Study. Journal of Clinical Medicine. 2024; 13(19):5919.
https://doi.org/10.3390/jcm13195919
Chicago/Turabian Style
Lesur, Olivier, Eric David Segal, Kevin Rego, Alain Mercat, Pierre Asfar, and Frédéric Chagnon.
2024. "Process-Specific Blood Biomarkers and Outcomes in COVID-19 Versus Non-COVID-19 ARDS (APEL–COVID Study): A Prospective, Observational Cohort Study" Journal of Clinical Medicine 13, no. 19: 5919.
https://doi.org/10.3390/jcm13195919
APA Style
Lesur, O., Segal, E. D., Rego, K., Mercat, A., Asfar, P., & Chagnon, F.
(2024). Process-Specific Blood Biomarkers and Outcomes in COVID-19 Versus Non-COVID-19 ARDS (APEL–COVID Study): A Prospective, Observational Cohort Study. Journal of Clinical Medicine, 13(19), 5919.
https://doi.org/10.3390/jcm13195919